동물용 치료제 시장 : 제품, 동물, 투여 경로, 최종사용자별 - 세계 예측(2025-2030년)

The Veterinary Therapeutics Market was valued at USD 38.05 billion in 2023, expected to reach USD 40.77 billion in 2024, and is projected to grow at a CAGR of 7.23%, to USD 62.04 billion by 2030.

The scope of the veterinary therapeutics market encompasses a wide range of products including pharmaceuticals, vaccines, and diagnostic tools designed for animal health care. Necessitated by the rising global pet ownership and the growing demand for livestock products, this market responds to the increasing prevalence of zoonotic diseases and the need for advanced animal healthcare solutions. Veterinary therapeutics are applied in the prevention, control, and treatment of diseases across a broad spectrum of end-users such as pet owners, veterinary hospitals, and livestock farmers. Key growth factors influencing the market include technological advances in drug development, rising animal healthcare awareness, and increased government initiatives. Recent potential opportunities lie in the growing trend of humanization of pets, the advancement of biopharmaceuticals, and the expansion into emerging markets with underserved veterinary needs. Moreover, digital solutions and telemedicine offer significant potential to streamline veterinary care. However, the market faces challenges such as stringent regulatory policies, high development costs, and the emergence of counterfeit products, which can stifle growth. Additionally, the lack of adequate veterinary infrastructure in developing regions limits market proliferation. Areas ripe for innovation include precision medicine, genomics, and the use of AI in diagnostics, which can enhance the accuracy and efficacy of treatment protocols. Another promising area is the development of sustainable and environmentally friendly therapeutic products, catering to the increasing demand for eco-conscious solutions. The market is characterized by a competitive landscape with major pharmaceutical companies investing in research and partnerships to expand their product offerings. To capitalize on emerging opportunities, stakeholders should focus on diversifying product portfolios, investing in cutting-edge research, and aligning strategies with evolving consumer expectations and regulatory landscapes. Overall, the veterinary therapeutics market is poised for substantial growth driven by continuous innovation and the expanding recognition of the importance of animal health in global health dynamics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Therapeutics Market

The Veterinary Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Improving veterinary care facilities in economies
  • Rising incidence of chronic diseases and accidental injuries in animals
• Market Restraints
  • High cost of veterinary therapeutics
• Market Opportunities
  • Growing new product approvals in economies
  • Increasing R&D activities to develop new therapeutics
• Market Challenges
  • Issues with quality management

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Therapeutics Market

A detailed market share analysis in the Veterinary Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Therapeutics Market

A strategic analysis of the Veterinary Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Unlimited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories Inc., ImmuCell Corporation, Indian Immunologicals Ltd., Merck & Co. Inc., Neogen Corporation, Novartis International AG, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol Group, and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Drug Type, Medicated Feed Additive, and Vaccines Type. The Drug Type is further studied across Anti-Inflammatory, Anti-Invectives, and Parasiticides. The Medicated Feed Additive is further studied across Amino Acids, Antibiotics, Online Pharmacy, and Retail Pharmacy. The Vaccines Type is further studied across Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines.
• Based on Animal, market is studied across Companion Animal and Livestock Animal.
• Based on Route of Administration, market is studied across Oral, Parenteral, and Topical.
• Based on End User, market is studied across Pharmacies & Drug Store, Veterinary Clinic, and Veterinary Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Improving veterinary care facilities in economies
    • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary therapeutics
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing new product approvals in economies
    • 5.1.3.2. Increasing R&D activities to develop new therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Issues with quality management
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Therapeutics Market, by Product

• 6.1. Introduction
• 6.2. Drug Type
  • 6.2.1. Anti-Inflammatory
  • 6.2.2. Anti-Invectives
  • 6.2.3. Parasiticides
• 6.3. Medicated Feed Additive
  • 6.3.1. Amino Acids
  • 6.3.2. Antibiotics
  • 6.3.3. Online Pharmacy
  • 6.3.4. Retail Pharmacy
• 6.4. Vaccines Type
  • 6.4.1. Attenuated Vaccines
  • 6.4.2. Inactivated Vaccines
  • 6.4.3. Recombinant Vaccines

7. Veterinary Therapeutics Market, by Animal

• 7.1. Introduction
• 7.2. Companion Animal
• 7.3. Livestock Animal

8. Veterinary Therapeutics Market, by Route of Administration

• 8.1. Introduction
• 8.2. Oral
• 8.3. Parenteral
• 8.4. Topical

9. Veterinary Therapeutics Market, by End User

• 9.1. Introduction
• 9.2. Pharmacies & Drug Store
• 9.3. Veterinary Clinic
• 9.4. Veterinary Hospital

10. Americas Veterinary Therapeutics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Therapeutics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Therapeutics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biogenesis Bago SA
• 2. Biovac Ltd.
• 3. Boehringer Ingelheim International GmbH
• 4. Ceva Sante Animale
• 5. Chanelle Pharma Unlimited
• 6. Dechra Pharmaceuticals PLC
• 7. Elanco Animal Health Incorporated
• 8. Eli Lilly and Company
• 9. Heska Corporation
• 10. Hester Biosciences Limited
• 11. IDEXX Laboratories Inc.
• 12. ImmuCell Corporation
• 13. Indian Immunologicals Ltd.
• 14. Merck & Co. Inc.
• 15. Neogen Corporation
• 16. Novartis International AG
• 17. Nutreco N.V.
• 18. Phibro Animal Health Corporation
• 19. Vetoquinol Group
• 20. Zoetis, Inc.